2115 studies found for:    "Genital Diseases, Female" | United States
Show Display Options
Rank Status Study
1 Recruiting The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies
Condition: Genital Diseases, Female
Interventions: Drug: Non-Buffered Lidocaine;   Drug: Buffered Lidocaine
2 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
3 Completed
Has Results
Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
4 Unknown  LANDA Embryo Freezing Technique.
Conditions: Primary Infertility;   Secondary Infertility;   Genital Diseases, Male;   Genital Diseases, Female
Intervention:
5 Recruiting Prognostic Markers of Gynecologic Cancers
Conditions: Gynecologic Disease;   Gynecologic Cancer
Intervention:
6 Not yet recruiting AirSeal®Insufflation Trocar/CO2 Absorption Study
Condition: Gynecologic Diseases
Interventions: Device: AirSeal trocar;   Device: Standard trocar
7 Recruiting Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients
Conditions: Laparotomy;   Gynecologic Diseases
Intervention: Other: Enhanced recovery protocol
8 Withdrawn Laparoscopic Supracervical Hysterectomy Versus Total Laparoscopic Hysterectomy
Condition: Gynecologic Diseases
Interventions: Procedure: Laparoscopic supracervical hysterectomy;   Procedure: Total laparoscopic hysterectomy
9 Completed
Has Results
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
Conditions: Esophageal Diseases;   Gastrointestinal Diseases;   Disorder of the Genitourinary System;   Gynecologic Diseases;   Kidney Diseases;   Liver Diseases;   Pancreatic Diseases;   Prostate Cancer;   Spinal Disease
Interventions: Device: Vigileo Monitor;   Device: FloTrac Sensor
10 Completed Novel Topical Therapies for the Treatment of Genital Pain
Condition: Female Genital Diseases
Interventions: Drug: Amitriptyline;   Drug: Baclofen;   Drug: Ketoprofen;   Drug: Ketamine;   Drug: Loperamide;   Drug: Gabapentin;   Drug: placebo
11 Recruiting Biomarkers for Gynecologic Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Benign Gynecological Disease
Intervention:
12 Recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
13 Completed Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting
Condition: Infertility
Intervention:
14 Completed
Has Results
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Conditions: Solid Tumors and Advanced Endometrial Cancer;   Endometrial Cancer;   Second-line Treatment;   VEGF
Intervention: Drug: TKI258
15 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Elagolix + Estradiol/Norethindrone Acetate
16 Recruiting A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Conditions: Vulvovaginal Atrophy;   Menopause;   Dyspareunia
Interventions: Drug: Estradiol Vaginal Capsule (EVC);   Drug: Placebo
17 Recruiting Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Placebo;   Drug: Elagolix;   Drug: Elagolix + Estradiol/Norethindrone Acetate
18 Recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions)
Conditions: Breast Cancer;   Cholangiocarcinoma;   Colorectal Cancer;   Head and Neck Neoplasms;   Lymphoma, Large-Cell, Anaplastic;   Melanoma;   Neuroendocrine Tumors;   Non-Small Cell Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer;   Papillary Thyroid Cancer;   Primary Brain Tumors;   Renal Cell Carcinoma;   Sarcomas;   Salivary Gland Cancers;   Adult Solid Tumor
Intervention: Drug: Entrectinib
19 Suspended Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
20 Recruiting Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasm
Interventions: Other: Placebo;   Drug: Veliparib;   Drug: Carboplatin;   Drug: Paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years